Zhou et al. (98) noted that rhamnocitrin could decrease LH levels in letrozole-induced PCOS SD rats, facilitating the recovery of ovarian tissue, possibly through enhanced PPAR-γ activity and the inhibition of the TGF-β1/Smad pathway. This evidence concerns the gene PPARG and polycystic ovary syndrome.